Voya Investment Management LLC Sells 8,787 Shares of STAAR Surgical Company $STAA

Voya Investment Management LLC cut its holdings in STAAR Surgical Company (NASDAQ:STAA) by 39.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,395 shares of the medical instruments supplier’s stock after selling 8,787 shares during the period. Voya Investment Management LLC’s holdings in STAAR Surgical were worth $236,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Linden Thomas Advisory Services LLC grew its holdings in shares of STAAR Surgical by 3.0% in the first quarter. Linden Thomas Advisory Services LLC now owns 20,978 shares of the medical instruments supplier’s stock valued at $370,000 after acquiring an additional 603 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of STAAR Surgical by 4.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,390 shares of the medical instruments supplier’s stock valued at $518,000 after acquiring an additional 1,267 shares in the last quarter. US Bancorp DE grew its holdings in shares of STAAR Surgical by 1,693.0% in the first quarter. US Bancorp DE now owns 2,044 shares of the medical instruments supplier’s stock valued at $36,000 after acquiring an additional 1,930 shares in the last quarter. Brooklyn Investment Group grew its holdings in shares of STAAR Surgical by 1,564.0% in the first quarter. Brooklyn Investment Group now owns 2,679 shares of the medical instruments supplier’s stock valued at $47,000 after acquiring an additional 2,518 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of STAAR Surgical by 29.6% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,076 shares of the medical instruments supplier’s stock valued at $248,000 after acquiring an additional 3,217 shares in the last quarter. 96.70% of the stock is owned by institutional investors.

STAAR Surgical Stock Performance

Shares of STAA stock opened at $26.85 on Tuesday. STAAR Surgical Company has a 52-week low of $13.50 and a 52-week high of $38.60. The company has a market capitalization of $1.33 billion, a PE ratio of -13.91 and a beta of 0.74. The business’s fifty day moving average is $25.69 and its 200 day moving average is $20.39.

Analyst Ratings Changes

Several equities analysts have weighed in on STAA shares. Mizuho increased their price objective on STAAR Surgical from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Wednesday, July 16th. Piper Sandler raised STAAR Surgical to a “hold” rating in a report on Wednesday, June 18th. Canaccord Genuity Group increased their price objective on STAAR Surgical from $20.00 to $28.00 and gave the company a “hold” rating in a report on Wednesday, August 6th. Finally, Stifel Nicolaus set a $28.00 price objective on STAAR Surgical and gave the company a “hold” rating in a report on Thursday, August 7th. Ten equities research analysts have rated the stock with a Hold rating, According to MarketBeat, STAAR Surgical has an average rating of “Hold” and an average price target of $20.67.

STAAR Surgical Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.